Mineralys Therapeutics (NASDAQ:MLYS) Price Target Raised to $42.00
Mineralys Therapeutics (NASDAQ:MLYS – Free Report) had its price objective hoisted by HC Wainwright from $30.00 to $42.00 in a research report released on Wednesday morning,Benzinga reports. HC Wainwright currently has a buy rating on the stock. A number of other equities research analysts have also issued reports on the stock. Guggenheim reaffirmed a “buy” […]
Mineralys Therapeutics (NASDAQ:MLYS – Free Report) had its price objective hoisted by HC Wainwright from $30.00 to $42.00 in a research report released on Wednesday morning,Benzinga reports. HC Wainwright currently has a buy rating on the stock. A number of other equities research analysts have also issued reports on the stock. Guggenheim reaffirmed a “buy” […]